Long-term hemodynamic results after cardiac transplantation

Area of Science:

• Cardiology
• Immunosuppression
• Transplantation Medicine

Background:

• Cyclosporine revolutionized cardiac transplantation survival since 1980.
• Long-term hemodynamic outcomes in cyclosporine-treated heart transplant recipients remain underreported.

Purpose of the Study:

• To evaluate the long-term hemodynamic performance of transplanted hearts in patients treated with cyclosporine.
• To compare these outcomes with a historical cohort treated with azathioprine and corticosteroids.

Main Methods:

• Analysis of annual cardiac catheterization data from 109 cyclosporine-treated recipients.
• Comparison with a concurrent group of 65 azathioprine-treated recipients.
• Assessment of hemodynamic variables including ejection fraction, cardiac index, pressures, and stroke work.

Main Results:

• Cyclosporine group showed normal ejection fraction and cardiac index, but elevated left ventricular end-diastolic and mean aortic pressures.
• Hemodynamic parameters remained stable over a 5-year follow-up, with only aortic diastolic pressure increasing.
• Compared to the azathioprine group, cyclosporine recipients had higher pressures and stroke work.

Conclusions:

• Long-term hemodynamic function in cyclosporine-treated heart transplant recipients is satisfactory and stable.
• Cyclosporine therapy is associated with significantly higher blood pressure compared to pre-cyclosporine immunosuppression.
• These findings highlight the need for vigilant blood pressure management in heart transplant patients on cyclosporine.